Exeter Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.42M | Buy |
21,536
+81
| +0.4% | +$17.4K | 2.07% | 13 |
|
|
2026
Q1 | $4.67M | Buy |
21,455
+1,037
| +5% | +$230K | 1.91% | 17 |
|
|
2025
Q4 | $4.67M | Buy |
20,418
+347
| +2% | +$79K | 1.98% | 14 |
|
|
2025
Q3 | $4.65M | Buy |
20,071
+398
| +2% | +$81K | 2.01% | 15 |
|
|
2025
Q2 | $3.65M | Sell |
19,673
-128
| -0.6% | -$23.8K | 1.63% | 22 |
|
|
2025
Q1 | $4.15M | Buy |
19,801
+137
| +0.7% | +$26.6K | 1.86% | 19 |
|
|
2024
Q4 | $3.49M | Buy |
19,664
+22
| +0.1% | +$4.04K | 1.6% | 20 |
|
|
2024
Q3 | $3.88M | Sell |
19,642
-1,187
| -6% | -$222K | 1.72% | 18 |
|
|
2024
Q2 | $3.57M | Sell |
20,829
-959
| -4% | -$159K | 1.7% | 20 |
|
|
2024
Q1 | $3.66M | Sell |
21,788
-198
| -0.9% | -$34.1K | 1.69% | 19 |
|
|
2023
Q4 | $3.57M | Buy |
21,986
+271
| +1% | +$39.5K | 1.73% | 20 |
|
|
2023
Q3 | $3.24M | Buy |
21,715
+617
| +3% | +$90.6K | 1.71% | 18 |
|
|
2023
Q2 | $2.86M | Buy |
21,098
+483
| +2% | +$70.8K | 1.48% | 23 |
|
|
2023
Q1 | $3.32M | Sell |
20,615
-332
| -2% | -$50.8K | 1.67% | 18 |
|
|
2022
Q4 | $3.39M | Sell |
20,947
-69
| -0.3% | -$10.6K | 1.76% | 18 |
|
|
2022
Q3 | $2.82M | Buy |
21,016
+643
| +3% | +$92.3K | 1.64% | 19 |
|
|
2022
Q2 | $3.12M | Sell |
20,373
-113
| -0.6% | -$17.3K | 1.74% | 19 |
|
|
2022
Q1 | $3.32M | Sell |
20,486
-1,300
| -6% | -$189K | 1.8% | 18 |
|
|
2021
Q4 | $2.97M | Sell |
21,786
-300
| -1% | -$35.4K | 1.63% | 22 |
|
|
2021
Q3 | $2.38M | Buy |
22,086
+100
| +0.5% | +$11.4K | 1.42% | 26 |
|
|
2021
Q2 | $2.53M | Hold |
21,986
| – | – | 1.47% | 25 |
|
|
2021
Q1 | $2.38M | Buy |
21,986
+700
| +3% | +$74.9K | 1.5% | 24 |
|
|
2020
Q4 | $2.28M | Sell |
21,286
-50
| -0.2% | -$4.8K | 1.58% | 21 |
|
|
2020
Q3 | $1.87M | Hold |
21,336
| – | – | 1.46% | 22 |
|
|
2020
Q2 | $2.1M | Sell |
21,336
-877
| -4% | -$77.2K | 1.74% | 20 |
|
|
2020
Q1 | $1.69M | Buy |
22,213
+1,150
| +5% | +$98K | 1.59% | 22 |
|
|
2019
Q4 | $1.86M | Sell |
21,063
-309
| -1% | -$25.7K | 1.45% | 28 |
|
|
2019
Q3 | $1.62M | Hold |
21,372
| – | – | 1.29% | 32 |
|
|
2019
Q2 | $1.55M | Buy |
21,372
+550
| +3% | +$43.2K | 1.3% | 32 |
|
|
2019
Q1 | $1.68M | Sell |
20,822
-555
| -3% | -$45.4K | 1.45% | 27 |
|
|
2018
Q4 | $1.97M | Buy |
21,377
+200
| +0.9% | +$17.6K | 1.86% | 20 |
|
|
2018
Q3 | $2M | Hold |
21,177
| – | – | 1.65% | 23 |
|
|
2018
Q2 | $1.96M | Buy |
21,177
+300
| +1% | +$29.3K | 1.73% | 21 |
|
|
2018
Q1 | $1.98M | Sell |
20,877
-1,650
| -7% | -$181K | 1.7% | 23 |
|
|
2017
Q4 | $2.18M | Buy |
+22,527
| New | +$2.12M | 1.9% | 19 |
|
Other funds holding ABBV
ATO
Exeter Financial's ABBV Position: Q2 2026 in Review
Exeter Financial increased its AbbVie (ABBV) stake by 0.38% in Q2 2026, buying an estimated $17.4K and bringing the position to 21,536 shares worth $5.42M. The position accounts for 2.07% of the portfolio, ranked #13.
Exeter Financial first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 1,758 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Exeter Financial held 21,536 shares of AbbVie worth $5.42M as of Q2 2026.
- Exeter Financial bought 81 AbbVie shares in Q2 2026, an estimated $17.4K.
- AbbVie made up 2.07% of Exeter Financial's portfolio in Q2 2026, its #13 holding.
- Exeter Financial first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 1,758 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.